97 related articles for article (PubMed ID: 1529159)
1. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
[TBL] [Abstract][Full Text] [Related]
2. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin treatment of anemia associated with multiple myeloma.
Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
Qiao ZH
Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121
[TBL] [Abstract][Full Text] [Related]
5. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.
Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E
Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
9. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M
Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069
[TBL] [Abstract][Full Text] [Related]
10. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
11. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
12. Therapy of anemia in patients with multiple myeloma.
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Acta Med Austriaca; 1995; 22(4):59-64. PubMed ID: 8835422
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia].
Gałeza-Obrepalska B; Dwilewicz-Trojaczek J; Paszkowska M; Kuratowska Z
Pol Tyg Lek; 1996 May; 51(19-22):285-8. PubMed ID: 9289712
[TBL] [Abstract][Full Text] [Related]
15. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.
Osterborg A; Brandberg Y; Molostova V; Iosava G; Abdulkadyrov K; Hedenus M; Messinger D;
J Clin Oncol; 2002 May; 20(10):2486-94. PubMed ID: 12011126
[TBL] [Abstract][Full Text] [Related]
17. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
19. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]